Characteristics, treatment patterns, healthcare resource use, and costs among adult patients diagnosed with neurofibromatosis type 1 and plexiform neurofibromas in the United States.
Saved in:
| Title: | Characteristics, treatment patterns, healthcare resource use, and costs among adult patients diagnosed with neurofibromatosis type 1 and plexiform neurofibromas in the United States. |
|---|---|
| Authors: | Yang X; Merck & Co., Inc., Rahway, NJ, USA., Obeng-Kusi M; Merck & Co., Inc., Rahway, NJ, USA. mavis.obeng-kusi@merck.com., Dettling T; Alexion, AstraZeneca Rare Disease, Boston, MA, USA., Adeyemi A; Alexion, AstraZeneca Rare Disease, Boston, MA, USA., Cunnington M; Analysis Group, Ltd., London, UK., Liu Q; Analysis Group, Inc., Boston, MA, USA., Lejeune D; Analysis Group, Inc., Montreal, Canada., Chen G; Analysis Group, Inc., Boston, MA, USA., Duh MS; Analysis Group, Inc., Boston, MA, USA., Jordan JT; Independent Consultant, AstraZeneca, Boston, MA, USA.; Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, USA. |
| Source: | BMC neurology [BMC Neurol] 2026 Jun 23; Vol. 26 (1). Date of Electronic Publication: 2026 Jun 23. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100968555 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2377 (Electronic) Linking ISSN: 14712377 NLM ISO Abbreviation: BMC Neurol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1471-2377 |
|---|---|
| DOI: | 10.1186/s12883-026-04868-8 |
